Archive for the ‘Lyme’ Category

Tick Borne Disease Working Group Meets in Jan.; Submit Request to Give Comments Now

https://www.lymedisease.org/tbdwg-jan20202/

TBD Working Group meets in DC, Jan. 28-29; submit request to give comments

Dec. 16, 2019

Long-Term Sequelae & Health-Related Quality-of-Life Associated with Lyme Disease: A Systematic Review

https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciz1158/5644106

Long-term sequelae and health-related quality-of-life associated with Lyme disease: A systematic review

Clinical Infectious Diseases, ciz1158, https://doi.org/10.1093/cid/ciz1158
Published:  27 November 2019

Abstract

Lyme disease (LD) is the most commonly reported vector-borne disease, but its clinical consequences remain uncertain. We conducted a systematic review of the long-term sequelae and health-related quality-of-life (HRQoL) associated with LD in North America and Europe. We performed searches in six electronic databases up to December 2018 following PRISMA guidelines, including observational studies reporting long-term sequelae, HRQoL, and prognostic factors. We included 46 studies, published between 1994 and 2019.Based on 21 studies reporting attributable outcomes, higher proportions of sequelae reported from exposed patients were: neck pain, myalgia, arthralgia, paresthesia, sleep disorder, poor appetite and concentration difficulties. Patients with PTLDS reported impaired HRQoL compared to the general US population. Included studies were highly heterogeneous in terms of study design, settings, patient characteristics and quality.

Patients with LD are more likely to report non-specific long-term sequelae, especially those experiencing persistent symptoms post-treatment. Opportunities exist for prospective longitudinal studies to better understand LD outcomes.

________________

For a great read on this PTLDS issue:  https://madisonarealymesupportgroup.com/2019/02/25/medical-stalemate-what-causes-continuing-symptoms-after-lyme-treatment/

Excerpt:

10-20% of Lyme disease patients who are promptly diagnosed and treated with an antibiotic within the first few weeks of infection, still end up with chronic disease. This is PTLDS.

30-40% of Lyme disease patients who have been infected for weeks to months before getting diagnosed, and THEN treated with an antibiotic, still end up with a chronic disease. This subgroup has no specific label but it has been referred to as “chronic Lyme disease,” or CLD.

60% OF LYME PATIENTS END UP WITH CHRONIC SYMPTOMS

Combining these two subgroups implies that up to 60% of people with Lyme disease will experience chronic illness as a result of this tick-borne disease.

Notice that authorities have only been including those diagnosed and treated early in their PTLDS group.  They have NOT be counting those diagnosed and treated late – which is far more common and constitutes nearly every patient I work with including myself and my husband.

 

 

 

Collins, Smith’s Bill To Combat Lyme & Other Tick-borne Diseases Ready to Be Signed into Law

https://www.boothbayregister.com/article/collins-smith-s-bill-combat-lyme-and-other-tick-borne-diseases-ready-be-signed-law

Collins, Smith’s bill to combat Lyme and other tick-borne diseases ready to be signed into law

Thu, 12/19/2019 – 4:00pm

Washington, D.C.— U.S. Senators Susan Collins (R-ME) and Tina Smith (D-MN) announced that legislation they authored to improve research, prevention, diagnostics, and treatment for tick-borne diseases passed the Senate today, Dec. 19, as part of the appropriations package. The legislation now heads to the President’s desk to be signed into law.

The Kay Hagan Tick Act unites the effort to confront the alarming public health threat posed by Lyme disease and other tick-borne diseases, which have risen exponentially from approximately 30,000 cases in 2003 to an estimated 450,000 last year.  Senators Collins and Smith renamed the bill in honor of former Senator Kay Hagan, who passed away on October 28th, 2019, due to complications from the tick-borne disease known as the Powassan virus.

In Maine alone, there were approximately 1,400 new cases of Lyme disease in 2018, a sharp increase from the 752 cases in 2010.  Far too many Americans with Lyme disease experience a complex diagnostic odyssey that takes months or even years, while suffering severe and debilitating symptoms.  In addition to the physical and emotional toll that Lyme disease takes, it is also expensive.  Medical costs of Lyme disease are estimated at $1.3 billion per year. When accounting for indirect medical costs, including loss of work, the annual costs balloon to $75 billion per year.

“Congress’ passage of the Tick Act is a major victory for the hundreds of thousands of Americans who contract Lyme and other tick-borne illnesses each year.  I am grateful for the countless advocates who shared their struggles with these diseases and conveyed the urgent need for this comprehensive, bipartisan bill,” said Senator Collins.  “With a national effort the Tick Act would establish, we can slow the spread of these devastating tick-borne illnesses and protect our health.”

“I was misdiagnosed by 23 doctors and specialists to the tune of $250,000 before getting an official diagnosis and proper treatment,” said Paula Jackson Jones, president and co-founder of Midcoast Lyme Disease Support & Education. “Enacting the Tick Act that Senator Collins introduced will provide a lifeline not only to patients but to medical providers. With funding available for research and education, we can get medical providers on the same page not only with improved diagnostic tools but better, more effective treatment options for their patients. With the Tick Act, and Senator Collins’ support in Washington, we can stem the growing threat of tick-borne disease.”

“Lyme is a frustrating and debilitating disease, but it’s a problem we can solve,” said Bonnie Crater, co-founder and board member at Center for Lyme Action.  “What is needed is dedicated and sustained effort by the federal government to address this growing public health threat.  Senators Collins and Smith’s legislation, the Kay Hagan Tick Act is a wonderful first step and is supported by more than 150 Lyme foundations and associations around the United States.”

“Lyme disease and other tick-borne pathogens continue to have significant impacts on public health in Maine and throughout much of the United States. The advancement of The Kay Hagan Tick Act signals a commitment from Congress to tackle the threats associated with ticks and to dedicate resources to managing tick-borne diseases on a national scale. This coordinated approach, focusing on research and education, will be critical in reducing the severe health and financial burdens associated with tick-borne diseases,” said James F. Dill, PhD, Pest Management Specialist and Coordinator, Diagnostic and Research Lab at the University of Maine Cooperative Extension.

“All of us at Global Lyme Alliance extend our heartfelt thanks to Senators Susan Collins and Tina Smith for their dedication to changing the outcome for suffering patients. It has been a long-haul for many of them, especially the kids who were forced to grow up with this poorly diagnosed and treated medical illness. Patients need real solutions, which the Kay Hagan Tick Act will bring!” said Scott Santarella, CEO, Global Lyme Alliance.

“My life was forever changed at age 6 when I was bitten by a tick the summer after first grade,” said 15-year-old Olivia Goodreau, founder of the LivLyme Foundation and TickTracker.  “Children are especially vulnerable to tick borne illnesses, but everyone is at risk. I am so grateful to Senator Susan Collins, her staff, the amazing Lyme advocates, and all those who’ve fought for passage of the Kay Hagan Tick Act. It will save lives by raising awareness and supporting early detection, diagnosis and treatment.”

“I was diagnosed with Lyme Disease the summer of 1986 when I was 14-years-old. Since then, my life has never been the same. I developed Bell’s palsy that paralyzed half my face, a heart murmur, and many other symptoms.  To this day, I continue to fight this disease,” said Heather Hearst, Founder of Maine-based Project Lyme and Advisory Board Member of the Bay Area Lyme Foundation.  “Over the years, I have watched Lyme grow from something that was rare and unknown to a threat that has affected thousands of Mainers, many of whom now suffer from chronic health issues. With the Kay Hagan Tick Act, we can finally put an end to the suffering and slow the spread of tick-borne diseases. I am so grateful to Senator Collins, Senator Smith, and the bipartisan coalition that worked together to make this a national priority”

Using a three-pronged approach, the Tick Act would:

1. Require the Department of Health and Human Services (HHS) to develop a National Strategy.  This would help expand research, improve testing and treatment, and coordinate common efforts across federal agencies including with DOD, USDA, EPA, the VA, and the Departments of Interior and Homeland Security

2. Reauthorize Regional Centers of Excellence in Vector-Borne Disease for five years at $10 million per year.  Funding for these centers, which was allotted in 2017, expires in 2021.  These Centers have led the scientific response against tick-borne diseases, which now make up 75 percent of vector-borne diseases in the U.S.  There are five centers located at universities in New York, California, Florida, Texas, and Wisconsin.

3. Authorize CDC Grants at $20 million per year that would be awarded to State Health Departments to improve data collection and analysis, support early detection and diagnosis, improve treatment, and raise awareness.  These awards would help states build a public health infrastructure for Lyme and other tick and vector-borne diseases and amplify their initiatives through public-private partnerships.

In September, Senator Collins, the Chairman of the Aging Committee, convened a field hearing at the University of Maine Cooperative Extension Diagnostic and Research Laboratory Tick Lab in Orono, where experts and witnesses discussed the critical need to pass the Tick Act.

In 2016, Congress took a critical step forward with the enactment of the 21st Century Cures Act, which created a federal Tick-Borne Diseases Working Group.  This Working Group released its first report in November 2018, which created several recommendations for next steps. With the findings of this report in mind, this legislation puts key recommendations into practice.

The Tick Act is supported by more than 155 organizations, including the Center for Lyme Action, the Entomological Society of America, National Association of Vector-Borne Disease Control Officials, the National Association of County and City Health Officials, Midcoast Lyme Disease Support & Education Organization in Maine, the Northeast Regional Center for Excellence in Vector Borne Diseases, the LivLyme Foundation, the Global Lyme Alliance, and The Avril Lavigne Foundation.

Senators Collins and Smith’s Tick Act was cosponsored by 32 Senators including Senators Shelley Moore Capito (R-WV), Richard Blumenthal (D-CT), Cindy Hyde-Smith (R- MS), Christopher Murphy (D-CT), John Boozman (R-AR), Margaret Hassan (D-NH), Angus King (I-ME), Mike Braun (R-IN), Bernie Sanders (I-VT), Cory Gardner (R-CO), Diane Feinstein (D-CA), Thom Tillis (R- NC), Elizabeth Warren (D-MA), Richard Burr (R-NC), Chuck Schumer (D-NY), Johnny Isakson (R-GA), Patty Murray (D-WA), Kirsten Gillibrand (D-NY), Tammy Baldwin (D-WI), Jeanne Shaheen (D-NH), Bob Menendez (D-NJ), Josh Hawley (R-MO), Tom Cotton (R-AR), Debbie Stabenow (D-MI), Bill Cassidy (R-LA), Bob Casey (D-PA), Michael Bennet (D-CO), Gary Peters (D-MI), and Chris Van Hollen (D-MD).

_________________

https://www.c-span.org/video/standalone/?c4840579/user-clip-rep-chris-smith-tick-act-passage”>http://https://www.c-span.org/video/standalone/?c4840579/user-clip-rep-chris-smith-tick-act-passage  Watch Video Here

Rep. Chris Smith on TICK Act Passage

For more:  https://madisonarealymesupportgroup.com/2019/09/10/maines-senator-collins-holds-field-hearing-on-tick-act/

 

 

Durango Mother’s Agonizing Search For a diagnosis Leads to Lyme Disease

https://durangoherald.com/articles/306986?fbclid=IwAR3xF-yYYlpDggNbj-

Durango mother’s agonizing search for a diagnosis leads to Lyme disease

‘I felt as if I had no purpose,’ Tasha Rayburn says
Tasha Rayburn became ill after giving birth to her first child. After months of doctors not knowing the cause, she received a proper diagnosis of Lyme disease in June.  

 

Patients Can Die When Lyme Carditis Is Not Treated

https://danielcameronmd.com/patients-die-lyme-carditis-not-treated/

PATIENTS CAN DIE WHEN LYME CARDITIS IS NOT TREATED

Lyme carditis can cause a broad range of symptoms. Patients may initially appear to have only a flu-like illness, however the severity of symptoms can change rapidly. In the article “Fatal Lyme carditis in New England: Two case reports,” Marx and colleagues highlight the importance of early recognition and treatment, even empirically, as Lyme carditis can be deadly when left untreated.

“Death can occur when Lyme carditis is untreated,” writes Marx, from the Centers for Disease Control and Prevention (CDC), in the Annuals of Internal Medicine. “Before this report, only 9 fatal cases were reported in the literature.”

Case 1: Waiting for infectious disease appointment

“A 57-year-old man from Vermont presented to a primary care physician after 1 week of fever, fatigue, shortness of breath, and chest pain,” writes Marx.

The evidence for Lyme disease included a disseminated erythema migrans rash, heart block, and a positive Lyme ELISA and IgM Western blot test. Yet, the patient was not treated.

Eight days later, the man presented to an emergency room with worsening symptoms. Physicians suspected Lyme disease, but antibiotics were not prescribed. Instead, a consultation with an infectious disease doctor was scheduled. Unfortunately, it never happened.

Only 12 days after his “initial presentation and before his scheduled appointment, the patient was found unresponsive,” writes Marx.

Case 2: Before the first dose of antibiotics

“A 49-year-old woman from Massachusetts presented to an emergency department with severe headache, nausea, and vomiting,” writes Marx. She was diagnosed and treated for a headache.

“Two weeks later, she saw her primary care physician and reported 2 episodes of syncope with bowel and bladder incontinence, persistent fatigue and nausea, and shortness of breath.”

“An ECG during the office visit showed atrioventricular dissociation.” Lyme disease tests were ordered.

Two days later, Lyme disease tests revealed a positive ELISA and IgM Western blot.

Lyme carditis can cause sudden death. These 2 cases highlight the importance of early recognition. And treatment, even if it’s empirical, may save lives. CLICK TO TWEETShe was prescribed doxycycline. But the next day, before she took the first dose, “her cardiac monitoring recorded atrioventricular dissociation evolving to ventricular tachycardia after an R-on-T electrical impulse,” writes Marx.

In both patients, an evaluation of postmortem heart tissue found lymphohistiocytic pancarditis with immunohistochemical and molecular evidence of the spirochete Borrelia burgdorferi.

“Spirochetes were directly visualized in endocardial tissue [taken] from the Massachusetts patient,” writes Marx.

Lyme carditis was high on the list of possible diagnoses, according to Marx. Yet, neither patient was treated empirically with antibiotics when Lyme disease testing was performed.

The patients might have received treatment had the guidelines been followed.²

“Guidelines recommend simultaneous initiation of empirical antibiotic therapy and Lyme serologic testing when Lyme carditis is suspected,” states Yeung et al.

“Lyme carditis can progress rapidly,” explains Marx, “waiting for confirmatory diagnostic therapy to initiate antibiotic treatment may result in negative outcomes.”

References:
  1. Marx GE, Leikauskas J, Lindstrom K, Mann E, Reagan-Steiner S, Matkovic E, Read JS, Kelso P, Kwit NA, Hinckley AF, Levine MA, Brown C. Fatal Lyme Carditis in New England: Two Case Reports. Ann Intern Med. 2019 Oct 22.
  2. Yeung C, Baranchuk A. Diagnosis and treatment of Lyme carditis: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;73:717-26

_________________

**Comment**

This is just asinine.  Doctors are so afraid of Lyme/MSIDS they would rather have patients die before prescribing antibiotics.  Things must change.

The body count continues to mount in Lyme land.